Horizon Pharma's forecast falls short By: MarketMinute.com Stock News April 12, 2016 at 14:23 PM EDT Horizon Pharma (Nasdaq: HZNP) forecast first and second quarter revenue that fell far short of analyst expectations sending the stock price plummeting $4.69 to $13.53. Related Stocks: Horizon Therapeutics